ACEI, angiotensin-converting enzyme inhibitor
Peripheral arterial endothelial dysfunction predicts future cardiovascular events in diabetic patients with albuminuria: a prospective cohort study
10
Hyperhomocysteinemia is an independent predictor of long-term clinical outcomes in Chinese octogenarians with acute coronary syndrome
8
The impact of DPP-4 inhibitors on long-term survival among diabetic patients after first acute myocardial infarction
11
The role of neurohormonal blockers in the primary prevention of acute-, early-, and late-onset anthracycline-induced cardiotoxicity
7
A systematic review of the predictors of disease progression in patients with autosomal dominant polycystic kidney disease
16
Long-term clinical outcome of patients with severe atherosclerotic renal artery stenosis after percutaneous transluminal renal angioplasty
9
High visceral fat with low subcutaneous fat accumulation as a determinant of atherosclerosis in patients with type 2 diabetes
7
Assessment of the effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis patients: a systematic review and meta-analysis on clinical trials
14
Hypertension and blood pressure variability management practices among physicians in Singapore
11
Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial
8
Use of monomeric and oligomeric flavanols in the dietary management of patients with type 2 diabetes mellitus and microalbuminuria (FLAVA trial): study protocol for a randomized controlled trial
9
Acute kidney injury after cardiac arrest
12
Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL 2 Study): study protocol for a randomised controlled trial
10
Urinary angiotensinogen level is associated with potassium homeostasis and clinical outcome in patients with polycystic kidney disease: a prospective cohort study
12
The SEISICAT study: a pilot study assessing 1 efficacy and safety of spironolactone in cats with congestive heart failure secondary to cardiomyopathy
45
Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy
11
<p>Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan</p>
11
Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial
11
Design, Synthesis, Docking Study and Antiplatelet Evaluation of New Thiosemicarbazide Derivatives Derived from Captopril
10
Angioedema in the emergency department: a practical guide to differential diagnosis and management
11